Emergent Biosolutions Inc. sell JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€1.86
Target price
20.11.24
-
Performance (%)
360.76%
End price
21.11.24
€8.58
Summary
This prediction ended on 21.11.24 with a price of €8.58. The SELL prediction by JPMorgan_Chase___Co_ for Emergent Biosolutions Inc. was trending in the completely wrong direction and closed with a performance of 360.76%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Emergent Biosolutions Inc. | -2.824% | -2.824% | 50.822% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,95 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 9,58 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 20,32 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 5,80 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co..
Ratings data for EBS provided by MarketBeat
In the thread Trading Emergent Biosolutions Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten